Sackler Family Agrees to $6.5 Billion Opioid Settlement
The Sackler family, owners of Purdue Pharma, have agreed to increase their financial contribution to a new bankruptcy settlement for opioid lawsuits to approximately $6.5 billion, up from a previous agreement of $6 billion. This development was reported by the Wall Street Journal.
The Sackler family, known as the proprietors behind Purdue Pharma, has agreed to enhance their financial contribution in a fresh bankruptcy settlement aimed at resolving opioid lawsuits.
According to reports by the Wall Street Journal, the tentative increase in the family's contribution is from $6 billion to roughly $6.5 billion.
This agreement signifies a critical step forward in addressing the multiple opioid-related claims that Purdue Pharma faces.
(With inputs from agencies.)
ALSO READ
Govt Releases 2025 Treaty Settlement Delivery Report Showing Rising Progress
U.S. Justice Department Secures $30 Million Settlement in Wanxiang Tariff Case
Legacy in Stone: Remembering Ram Sutar's Contributions to Indian Art
Wanxiang Settlement Concludes Decade-long Tariff Litigation
PM Narendra Modi conferred with Order of Oman for his contributions to strengthening bilateral ties.

